Assessment of Treatment Intensity as a Predictor of Benefit in DLBCL

Patients with newly-diagnosed DLBCL receiving R-CHOP at or near full-dose intensity have improved overall survival, according to study authors.

from Latest articles from Cancer Therapy Advisor Hematologic Cancers http://bit.ly/2If4wtM